AstraZeneca boss ‘wants to shift stock market listing to US’

Report claims CEO Pascal Soriot talked in private about moving UK’s most valuable listed company and considered shifting its domicile AstraZeneca’s chief executive Pascal Soriot has reportedly said that he would like to shift the company’s stock market listing from the UK to the US. The boss of…